Alzheimer Disease in Breast Cancer Survivors
JAMA Network Open · 20.06.2025 · 8 (6) · e2516468
DOI: 10.1001/jamanetworkopen.2025.16468 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 20.06.2025. Verfasst von Su-Min Jeong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Alzheimer Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Importance Cancer-related cognitive impairment is a common concern after breast cancer treatment. However, the association between breast cancer survivorship and the risk of Alzheimer dementia (AD) remains unclear.
Objective
To evaluate the risk of AD among breast cancer survivors compared with cancer-free controls and examine the potential association of cancer treatments with AD risk. Design, Setting, and Participants This retrospective cohort study used data from the Korean National Health Insurance Service. A total of 70 701 patients who underwent breast cancer surgery between January 1, 2010, and December 31, 2016, were included and matched with cancer-free controls (1:3). Participants were followed up for a median (IQR) of 7.3 (5.7-9.0) years. Data analysis was performed from January 2024 to June 2024. Exposures Breast cancer diagnosis, surgery, and subsequent treatments, including anthracycline chemotherapy and radiation therapy. Main Outcomes and Measures The primary outcome was the incidence of AD. Subdistribution hazard ratios (SHRs) and 95% CIs were calculated using competing risk regression models, adjusting for sociodemographic factors and comorbidities.
Results
Among 70 701 breast cancer survivors (mean [SD] age, 53.1 [8.5] years), 1229 cases of AD were detected, with an incidence rate of 2.45 per 1000 person-years. Survivors exhibited a slightly lower risk of AD compared with cancer-free controls (SHR, 0.92; 95% CI, 0.86-0.98), especially among individuals 65 years or older (SHR, 0.92; 95% CI, 0.85-0.99). However, landmark analyses found that this lower risk did not persist beyond 5 years of survival. Cancer treatment with radiation therapy (adjusted HR, 0.77; 95% CI, 0.68-0.87) was associated with reduced risk of AD among survivors. Conclusions and Relevance This cohort study of breast cancer survivors found a lower risk of AD compared with cancer-free controls, despite common concerns about cognitive decline after treatment. The findings suggest certain cancer treatments potentially have benefits for lower AD risk. Further research is needed to assess the long-term risk of AD in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Department of Clinical Research Design and Evaluation, The Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.
- Department of Family Medicine, Executive Healthcare Clinic, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Family Medicine, CHA Gumi Medical Center, CHA University School of Medicine, Gumi, Republic of Korea.
- Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Zitieren
APA
Jeong, S. M., Jung, W., Cho, H., Choi, H. L., Jeon, K. H., Nam, K. W., Lee, Y. G., Kim, B., Han, K., & Shin, D. W. (2025). Alzheimer Disease in Breast Cancer Survivors. JAMA Network Open, 8(6), e2516468. https://doi.org/10.1001/jamanetworkopen.2025.16468
Vancouver
Jeong SM, Jung W, Cho H, Choi HL, Jeon KH, Nam KW, et al. Alzheimer Disease in Breast Cancer Survivors. JAMA Network Open. 2025;8(6):e2516468. doi:10.1001/jamanetworkopen.2025.16468
BibTeX
@article{Jeong2025,
author = {Jeong, Su-Min and Jung, Wonyoung and Cho, Hyeonjin and Choi, Hea Lim and Jeon, Keun Hye and Nam, Ki-Woong and Lee, Yun-Gyoo and Kim, Bongseong and Han, Kyungdo and Shin, Dong Wook},
title = {Alzheimer Disease in Breast Cancer Survivors},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {6},
pages = {e2516468},
doi = {10.1001/jamanetworkopen.2025.16468}
}
EUVIMED